Nectintx
1 known investors
Nectin is a biotech developing a pipeline of targeted immunotherapies, including immuno-oncology antibodies and antibody-drug conjugates (ADCs). Its lead anti-PVR asset is in phase 1 clinical trials, addressing PVR expression as a rate-limiting factor for approved immune checkpoint inhibitors.
BiotechMedical Devices